Related Experiment Video

Updated: Aug 29, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

A nonviral carrier for targeted gene delivery to tumor cells

Jacoba van Zanten1, Berber Doornbos-Van der Meer, Sandrine Audouy

  • 1Department of PLG/Medical Biology, Academic Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. J.van.Zanten@med.rug.nl

Cancer Gene Therapy
|December 27, 2003
PubMed

Insights

Researchers created a targeted DNA delivery system using SAINT/DOPE lipids coupled to monoclonal antibodies. This system enhances gene delivery to specific cancer cells, improving transfection efficiency for targeted cancer therapies.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Nanomedicine

Background:

  • Nonviral gene delivery systems are crucial for therapeutic applications.
  • Targeted delivery enhances efficacy and reduces off-target effects.
  • Cationic lipids like SAINT/DOPE are effective DNA carriers.

Purpose of the Study:

  • To develop a nonviral, cationic, targeted DNA-carrier system.
  • To couple SAINT/DOPE lipids to tumor-specific monoclonal antibodies (MoAbs).
  • To evaluate the binding and transfection efficiency of the targeted system.

Main Methods:

  • Coupling of SAINT/DOPE lipids to MOC31 and Herceptin monoclonal antibodies.
  • Covalent attachment under nonreducing conditions.
  • Assaying binding and transfection efficiency in target and non-target cells.

Main Results:

  • SAINT/DOPE lipoplexes demonstrated effective transfection of various cell lines.
  • Targeted MoAb-SAINT/DOPE lipoplexes showed preferential binding to target cells.
  • Herceptin-SAINT/DOPE lipoplexes significantly improved transfection of target cells.

Conclusions:

  • Monoclonal antibody-coupled SAINT/DOPE lipoplexes enable targeted gene delivery.
  • This approach achieves higher transfection rates in target cancer cells.
  • The developed system holds promise for targeted cancer gene therapy.

More Related Videos

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.